# Ian George

> Ian George is a Series A investor at New Wave Ventures backing Medical and Health Care. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [New Wave Ventures](https://shizune.co/investors/profile/new-wave-ventures)
- Location: Upper Heyford, United Kingdom
- Total investments: 1
- Last investment: Sep 2015
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/ian-george-30885a/

Ian George is a Series A investor at New Wave Ventures in Upper Heyford focused on Medical and Health Care. Ian is a founder director of Enigma Diagnostics and is responsible for the company's business development & IP functions. Previously he worked as a Business Consultant at The Technology Partnership and prior to that, he was a Business Development Manager at the Defence Science Technology Laboratory where he was responsible for thecommercialisation of healthcare technology and the formation of several spin-out companies including Enigma and P2i Ltd.Earlier in his career Ian worked in technology commercialisation for Unilever Research and Sequa Corp. Ian is a non-executive director of Discuva and Cambridge Scientific Innovations, two New Wave Ventures portfolio companies. Ian lives in Wiltshire. After a period serving as a member of New Wave’s Advisory Board, Ian was appointed CSO in October 2013.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 100% |
| Health Care | 1 | 100% |
| Information Technology | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Xerion Healthcare | Xerion Healthcare develop nanoparticles that are used to improve treatment of cancer. The nanoparticles are injected into tumours just prior to standard radiotherapy and act to enhance the effectiveness of the treatment, amplifying the dose of free radicals generated by the X-rays. The nanoparticles are based on titanium dioxide, a common,non-toxic, semiconductor material. Xerion Healthcare are currently developing the treatment for head and neck and pancreatic tumours. | $2M | Series A | Sep 04, 2015 |  |

1 of 1 investments shown.

## About New Wave Ventures

VC Fund · London, United Kingdom

New Wave Ventures is a privately owned fund seeking the opportunity to invest for the long term in companies with significant growth potential. Their target initial investment is £500,000 to £2,000,000. They invest their own money without the need for external investors or borrowings. They are not driven by the need to service interest charges orto dispose of their investments by an artificial deadline. They do not believe in using leverage to boost their returns. They are willing to co-invest with like-minded investors, although their preference is to be the sole investor alongside owner-managers.

4 contacts available at New Wave Ventures.

| Name | Title | Profile |
| --- | --- | --- |
| Clare Twemlow | Chief Financial Officer | https://shizune.co/investors/profile/clare-twemlow |
| Ian George | Chief Scientific Officer | https://shizune.co/investors/profile/ian-george |
| Paul Newey | Co-Founder | https://shizune.co/investors/profile/paul-newey |
| Tim Bullock | Co-Founder | https://shizune.co/investors/profile/tim-bullock |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Ian George invest in?

Ian George invests primarily in Medical, Health Care and Information Technology startups, most often at Series A stage. Most of the 1 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Ian George last invest?

The most recent investment recorded for Ian George closed in Sep 2015. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co